PET/CT in Psoriatic Arthritis

Completed

• Conditions: Psoriatic Arthritis
• Interventions: Radiation: FDG-PET/CT scan

• Registration Number: NCT01654198
• Lead Sponsor: University of Pennsylvania

Brief Summary

When patients with psoriasis develop joint pain, it is often hard to decide whether or not the pain is due to psoriatic arthritis (PsA). At this time, doctors use information from the history and physical exam to determine the diagnosis. X-rays, magnetic resonance imaging (MRI) and ultrasound have been used to help with the diagnosis but all three have limitations. A newer imaging technique, whole body Positron Emission Tomography/Computed Tomography (PET/CT) uses the idea that inflammatory cells take up sugar to locate inflammation in the body. Because patients with PsA have inflammatory cells in their joints and tendons, this type of scan allows the physician to take a picture of the whole body and locate inflammation. The investigators have found that some patients with psoriasis (but without arthritis) have inflammation in joints and tendons even before the patient has symptoms. In this study, the investigators will explore how well PET/CT works for assessing inflammation in patients with PsA. This would be a very exciting tool that could be used to find and treat inflammation before it causes damage or pain.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2012-07
• Study First Submitted: 2012-07-27
• Study First Submitted QC: 2012-07-30
• Study First Posted: 2012-07-31
• Primary Completion: 2018-10-02
• Study Completion: 2018-10-02
• Status Verified: 2020-12
• Last Update Submitted: 2020-12-07
• Last Update Posted: 2020-12-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

• Age 18-80,
• active psoriatic arthritis (joint or enthesis inflammation)

Read More

Exclusion Criteria

• Diabetes,
• pregnant,
• no active PsA

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Psoriatic arthritis	FDG-PET/CT scan	-

Primary Outcome Measures

Name	Time	Method
Primary outcome is inflammation as measured by SUVmax and metabolic volumetric product in the joints and entheses.	At the discretion of the PI

Secondary Outcome Measures

Name	Time	Method
Correlation of local inflammation in joints and enthesis with systemic inflammatory markers including IL6 and high sensitivity CRP.	At the discretion of the PI

Trial Locations

Locations (1)

University of Pennsylvania Division of Rheumatology; 🇺🇸 Philadelphia, Pennsylvania, United States